Darolutamide Observational Study in non-metastatic castration-resistant prostate cancer patients (DAROL)

First published 28/02/2020

Last updated 29/03/2024

EU PAS number:

EUPAS31734

Study

Ongoing

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Darolutamide Observational Study in non-metastatic castration-resistant prostate cancer patients (DAROL)

Secondary tabs

Share this page